Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Harvard School of Public Health |
---|---|
Information provided by: | Harvard School of Public Health |
ClinicalTrials.gov Identifier: | NCT00197587 |
The purpose of this study is to find the most effective and safe treatment to prevent the passage of HIV from an infected mother to her baby.
Condition | Intervention |
---|---|
HIV Infection Infant Risk for HIV Infection by MTCT |
Drug: Nevirapine |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Placebo Control, Factorial Assignment |
Estimated Enrollment: | 1200 |
Ages Eligible for Study: | 15 Years to 45 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Study ID Numbers: | HSC 10411/9912BOTS |
Study First Received: | September 12, 2005 |
Last Updated: | September 28, 2006 |
ClinicalTrials.gov Identifier: | NCT00197587 |
Health Authority: | Botswana: Ministry of Health; United States: Federal Government |
Virus Diseases Nevirapine Sexually Transmitted Diseases, Viral HIV Infections |
Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome Retroviridae Infections Immunologic Deficiency Syndromes |
Communicable Diseases Anti-Infective Agents RNA Virus Infections Slow Virus Diseases Anti-HIV Agents Molecular Mechanisms of Pharmacological Action Immune System Diseases Enzyme Inhibitors |
Infection Antiviral Agents Pharmacologic Actions Reverse Transcriptase Inhibitors Anti-Retroviral Agents Therapeutic Uses Lentivirus Infections Nucleic Acid Synthesis Inhibitors |